The tirzepatide syringe dosage requires reading the dosage chart carefully
We also ensure Tirzepatide is not used if you are pregnant, breastfeeding, or planning to become pregnant
You pay the same transparent price regardless of your Tirzepatide dose
Semaglutide: GLP-1 Receptor Agonist Semaglutide activates a single receptor type: GLP-1 (Glucagon-like peptide-1): Slows gastric emptying, suppresses appetite at the hypothalamic level, and stimulates insulin secretion in a glucose-dependent manner Semaglutide has been studied extensively since 2017 and has the longest track record of any injectable GLP-1 agonist on the market
This page has been reviewed for clinical accuracy, safety, and alignment with current FDA guidance, ADA 2026 Standards of Care, and WHO GLP-1 guidelines for all information related to semaglutide, tirzepatide, retatrutide, and GLP-1/GIP weight loss therapy.